- Emergency surgery → go. Optimize on the way; do not delay for testing.
- Active cardiac condition (ACS, decompensated HF, severe valve disease, unstable arrhythmia) → fix it first.
- Low risk (RCRI 0–1 / <1% MACE) → proceed.
- Elevated risk + good functional capacity (≥4 METs, e.g., 2 flights of stairs) → proceed.
- Elevated risk + poor/unknown capacity → BNP/NT-proBNP (2024) → stress test only if it would change management anyway.
- "Cardiac clearance" does not exist — write risk + recommendations.
Pathophysiology in 60 seconds
⌄
- Surgery = stress test: catecholamines, bleeding, hypotension, hypercoagulability, anemia, pain.
- Most perioperative MIs are type 2 (supply–demand), silent, and found only with troponin → MINS (myocardial injury after non-cardiac surgery) predicts 30-day death.
- Pre-op revascularization of stable CAD does not reduce risk (CARP).
Risk tools
⌄
| RCRI (1 point each) |
|---|
| High-risk surgery (intraperitoneal, intrathoracic, suprainguinal vascular) |
| Ischemic heart disease |
| Heart failure |
| Cerebrovascular disease |
| Insulin-treated diabetes |
| Creatinine >2.0 mg/dL |
0 → ~4% · 1 → ~6% · 2 → ~10% · ≥3 → ~15% (MACE in modern cohorts). Alternatives: NSQIP calculator, Gupta MICA.
- ≥4 METs (2 flights of stairs, brisk walk 4 mph, heavy housework) = adequate. DASI score >34 more objective.
- BNP ≥92 pg/mL or NT-proBNP ≥300 → higher risk → consider post-op troponin surveillance.
- ECG: elevated-risk surgery with known heart disease. TTE: unexplained dyspnea, murmur, HF change.
Medication plan
⌄
| Drug | Plan |
|---|---|
| β-blocker | Continue if chronic. Do not start on the day of surgery (POISE). |
| Statin | Continue; start if indicated |
| ACEi/ARB | Continue or hold 24 h — individualize (hold if hypotension risk); restart early |
| SGLT2 inhibitor | Hold 3 days (ertugliflozin 4 days) — euglycemic DKA |
| Aspirin (secondary prevention) | Continue for most; hold for closed-space surgery (spine, intracranial, posterior eye) |
| Aspirin (primary prevention) | Hold 7 days |
| P2Y12 with recent stent | Delay elective surgery: ≥6 months after DES (≥3 months if surgery delay is harmful); 12 months after ACS ideally. Keep aspirin. |
| Drug | Low/moderate bleed risk | High bleed risk |
|---|---|---|
| Apixaban / rivaroxaban / edoxaban | Hold 1 day | Hold 2 days |
| Dabigatran (CrCl ≥50) | 1 day | 2 days |
| Dabigatran (CrCl <50) | 2 days | 4 days |
| Warfarin | Hold 5 days, INR day before | Same |
- No bridging for AF (BRIDGE). Bridge only selected: mechanical mitral valve, recent (<3 months) VTE/stroke, very high thrombotic risk.
- Restart DOAC 24 h after low-risk, 48–72 h after high-risk surgery.
- Basal insulin: give 75–80% night before / morning of surgery.
- GLP-1 RA: most continue; for high-aspiration-risk patients, liquid diet 24 h before (2024 multisociety guidance).
- Stress-dose steroids if chronic steroid user (see adrenal page).
How to write the note
⌄
"Patient is at elevated risk (RCRI 2: insulin-treated DM, Cr 2.3) for intermediate-risk surgery. Functional capacity ≥4 METs. No active cardiac conditions. No further testing will change management. Recommend: continue metoprolol and atorvastatin, hold empagliflozin 3 days prior, post-op troponin ×2 given elevated BNP."
Board corner
⌄
| Stem | Answer |
|---|---|
| Elevated risk, climbs 3 flights | Proceed without testing |
| Stable CAD, abnormal stress test, elective hip | Revascularization does not reduce periop risk — proceed with medical therapy |
| DES 2 months ago, elective cholecystectomy | Delay if possible (≥6 months) |
| AF on apixaban, low-bleed surgery | Hold 1 day, no bridge |
| Start metoprolol morning of surgery? | No (POISE: stroke, death) |
References
⌄
- Thompson A, et al. 2024 AHA/ACC/ACS/ASNC/HRS/SCA/SCCT/SCMR/SVM Guideline for Perioperative Cardiovascular Management for Noncardiac Surgery. Circulation. 2024;150:e351.
- Douketis JD, et al. PAUSE. JAMA Intern Med. 2019 · BRIDGE. NEJM. 2015.
- POISE (Lancet 2008) · CARP (NEJM 2004) · VISION.